Blog Category

News

September

September

Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and...

September 18th, 2020

A Phase 3 study concludes that a simplified regimen of one dose of NEPA and dexamethasone (DEX) has comparable anti-emetic efficacy to regimens with g...

Read article

August

July

June

May

Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Eva...

May 13th, 2020

Data to be Featured in the American Society of Clinical Oncology Annual 2020 Virtual Scientific Program on May 29, 2020 at 8:00 a.m. EDT

Read article

April

March

February

January

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company o...

January 27th, 2020

Berlin-Chemie AG has been granted exclusive rights to import, distribute, promote, market and sell AKYNZEO® and ONICIT® (ALOXI®) in Russia and CIS reg...

Read article

Lyfebulb and Helsinn Announce 11 Finalists for the Third Annual Lyfebulb-Helsinn...

January 14th, 2020

The Award recognizes Patient Entrepreneurs demonstrating outstanding innovations which advance solutions in the prevention, management or care of canc...

Read article